antiretroviral treatment

HIV Elimination in South Africa Could Be Achieved by Current Treatment Policy

Published October 22, 2013

HIV elimination in South Africa could be achieved by current treatment policy
The current antiretroviral treatment policy in South Africa could lead to elimination of HIV within the country over the next 24 to 34 years, but a universal test… Continue reading →

Therapeutic Options in Docetaxel-Refractory Metastatic Castration-Resistant Prostate Cancer: A Cost-Effectiveness Analysis.

Published May 31, 2013

Therapeutic options in docetaxel-refractory metastatic castration-resistant prostate cancer: a cost-effectiveness analysis.

PLoS One. 2013; 8(5): e64275
Zhong L, Pon V, Srinivas S, Nguyen N, Frear M, Kwon S, Gong C, Malmstrom R, Wilson L

Docetaxel is an established first-line… Continue reading →

How Does Antiretroviral Treatment Attenuate the Stigma of HIV? Evidence From a Cohort Study in Rural Uganda.

Published May 15, 2013

How Does Antiretroviral Treatment Attenuate the Stigma of HIV? Evidence from a Cohort Study in Rural Uganda.

AIDS Behav. 2013 May 14;
Tsai AC, Bangsberg DR, Bwana M, Haberer JE, Frongillo EA, Muzoora C, Kumbakumba E, Hunt PW, Martin… Continue reading →

Prevalence of Transmitted HIV Drug Resistance in Iran Between 2010 and 2011.

Published April 30, 2013

Prevalence of Transmitted HIV Drug Resistance in Iran between 2010 and 2011.

PLoS One. 2013; 8(4): e61864
Jahanbakhsh F, Hattori J, Matsuda M, Ibe S, Monavari SH, Memarnejadian A, Aghasadeghi MR, Mostafavi E, Mohraz M, Jabbari H, Kamali K,… Continue reading →

Successful Use of Cyclophosphamide as an Add-on Therapy for Multiple Myeloma Patients With Acquired Resistance to Bortezomib or Lenalidomide.

Published April 23, 2013

Successful use of cyclophosphamide as an add-on therapy for multiple myeloma patients with acquired resistance to bortezomib or lenalidomide.

Case Rep Hematol. 2013; 2013: 651902
Ito S, Oyake T, Murai K, Ishida Y

Novel agents such as thalidomide, lenalidomide,… Continue reading →

Closing the Door to Human Immunodeficiency Virus.

Published March 13, 2013

Closing the door to human immunodeficiency virus.

Protein Cell. 2013 Feb; 4(2): 86-102
Kang Y, Guo J, Chen Z

The pandemic of human immunodeficiency virus type one (HIV-1), the major etiologic agent of acquired immunodeficiency disease (AIDS), has led… Continue reading →

[Remission, Response, and Its Prediction in Depressive Inpatients.]

Published February 28, 2013

[Remission, Response, and its Prediction in Depressive Inpatients.]

Psychother Psychosom Med Psychol. 2013 Feb 26;
Harbeck S, Kliem S, Wollburg E, Braukhaus C, Kröger C

Using mean comparisons and effect sizes to report effects of inpatient treatment, this not… Continue reading →

Depression & Anxiety.Cures for Depression.Anxiety Definition.Remedies for Anxiety

Published January 2, 2013

Depression & Anxiety.Cures For Depression.Anxiety Definition.Remedies For Anxiety – free-review-tips.info ,Depression & Anxiety.cures for depression.anxiety definition.remedies for anxiety.,bipolar treatment,social anxiety,cures for depression,anxiety definition,remedies for anxiety,anxiety disorder symptoms,anxiety test,natural remedies for depression,anxiety disorder treatment,natural remedies for anxiety,how to deal with… Continue reading →

Drug and Alcohol Rehabilitation: What Can We Learn From the Evolution of Protein-Ligand Interactions to Aid the Design of New Therapeutics?

Published December 15, 2012

What can we learn from the evolution of protein-ligand interactions to aid the design of new therapeutics?

Filed under: Drug and Alcohol Rehabilitation

PLoS One. 2012; 7(12): e51742
Higueruelo AP, Schreyer A, Bickerton GR, Blundell TL, Pitt WR

Efforts… Continue reading →

First-Line Antiretroviral Treatment Outcome in a Patient Presenting an HIV-1/2 Multiclass Drug Resistant Infection.

Published December 15, 2012

First-line antiretroviral treatment outcome in a patient presenting an HIV-1/2 multiclass drug resistant infection.

Filed under: Addiction Rehab

J Int AIDS Soc. 2012; 15(6): 18224
Castro E, Recordon-Pinson P, Papuchon J, Vetter B, Shah C, Schupbach J, Fleury H,… Continue reading →